MEI Pharma Inc. (MEIP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

MEI Pharma Inc.

NASDAQ: MEIP · Real-Time Price · USD
3.07
0.29 (10.43%)
At close: Sep 10, 2025, 3:59 PM

MEI Pharma Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a 65.3M 1.46M 5.89M 32.73M 8.73M 11.41M 9.69M 18.22M 13.39M 10.12M 2.42M 9.17M 3.83M
Cost of Revenue
n/a 61K 368K -247K 86K 85K -3.56M 464K 457K 446K n/a 358K n/a n/a n/a n/a 405K 494K 509K
Gross Profit
n/a -61K -368K 247K -86K -85K 68.86M 993K 5.44M 32.29M 8.73M 11.06M 9.69M 18.22M 13.39M 10.12M 2.01M 8.67M 3.33M
Operating Income
-2.77M -3.45M -8.35M -18.98M -9.83M -11.93M 55.28M -11.08M -16.39M 8.93M 18.22M -16.2M -21.56M -11.23M -14.47M -12.81M -22.09M -19.2M -15.59M
Interest Income
202K 279K 355K 608K 706K 869K 1.09M 1.06M 957K 845K 480K 206K 60K 11K 8K 13K 58K 164K 275K
Pretax Income
-2.57M -2.68M -8.01M -18.41M -9.13M -11.06M 56.37M -10.03M -15.44M 10.25M -16.62M -16.06M -8.72M -5.77M -11.88M -5.71M -31.31M -11.45M -2.09M
Net Income
-2.57M -2.68M -8.01M -18.41M -9.13M -11.06M 56.37M -10.03M -15.44M 10.25M -16.62M -16.06M -8.73M -12.16M -17.51M -8.38M -25.62M -8.03M 710K
Selling & General & Admin
2.4M 3.14M 5.19M 4.01M 4.52M 7.93M 6.53M 9.97M 7.18M 8.5M 7.49M 5.77M 8.93M 7.93M 7.91M 6.63M 6.21M 5.65M 5.92M
Research & Development
369K 308K 3.16M 3.94M 5.22M 3.91M 3.48M 2.57M 15.1M 15.31M 19.46M 21.84M 22.32M 21.53M 19.95M 16.29M 17.88M 22.22M 13M
Other Expenses
n/a n/a n/a n/a n/a n/a -3.46M -12K -4K -4K -2K n/a n/a n/a n/a 4K -13K n/a -5K
Operating Expenses
2.77M 3.45M 8.35M 7.96M 9.74M 11.85M 6.56M 12.54M 22.29M 23.81M 26.95M 27.61M 31.25M 29.46M 27.86M 22.93M 24.1M 27.87M 18.91M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -86K -85K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.77M 3.45M 8.35M 18.98M 9.83M 11.93M 10.02M 12.54M 22.29M 23.81M 26.95M 27.61M 31.25M 29.46M 27.86M 22.93M 24.5M 28.37M 19.42M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.6M n/a n/a -5.47M -2.6M -7.09M 9.21M -7.25M -13.5M
Shares Outstanding (Basic)
6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.65M 6.34M 5.63M 5.63M 5.63M 5.63M 5.62M
Shares Outstanding (Diluted)
6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.66M 6.65M 6.41M 5.7M 5.8M 5.63M 5.72M 5.75M
EPS (Basic)
-0.39 -0.4 -1.2 -2.76 -1.37 -1.66 8.46 -1.51 -2.32 1.54 -2.49 -2.44 -1.31 -2 -3.2 -1.6 -4.6 -1.4 0.20
EPS (Diluted)
-0.39 -0.4 -1.2 -2.76 -1.37 -1.66 8.46 -1.51 -2.32 1.54 -2.49 -2.41 -1.31 -2.8 -3.6 -2.6 -4.6 -2.6 -2.2
EBITDA
-2.77M -3.45M -7.64M -18.28M -9.74M -10.98M 55.28M -9.56M -16.39M 8.93M -18.12M -16.11M -21.56M -17.55M -20.03M -12.74M -16.32M -15.7M -12.71M
EBIT
-2.77M -3.45M -8.01M -18.41M -9.83M -11.06M 55.28M -11.08M -16.39M 10.25M -18.22M -16.2M -21.56M -17.63M -20.11M -12.81M -16.39M -15.77M -12.78M
Depreciation & Amortization
n/a n/a 368K 125K 86K 85K 87K 464K 457K 446K 99K 152K -12.77M 75K 77K 70K 72K 74K 69K